Angiotensin 1/2 (1-6)
mRNA synthesis
In vitro transcription of capped mRNA with modified nucleotides and Poly(A) tail
Tyramide Signal Amplification (TSA)
TSA (Tyramide Signal Amplification), used for signal amplification of ISH, IHC and IC etc.
Phos Binding Reagent Acrylamide
Separation of phosphorylated and non-phosphorylated proteins without phospho-specific antibody
Cell Counting Kit-8 (CCK-8)
A convenient and sensitive way for cell proliferation assay and cytotoxicity assay
SYBR Safe DNA Gel Stain
Safe and sensitive stain for visualization of DNA or RNA in agarose or acrylamide gels.
Inhibitor Cocktails
Protect the integrity of proteins from multiple proteases and phosphatases for different applications.
Angiotensin I/II(1-6)是一种多肽(ASP-ARG-VAL-TYR-ILE-HIS),含有氨基酸1-6,由血管紧张素肽I/II转换而来。
Angiotensin I是由肾素作用于血管紧张素原形成的,血管紧张素原是一种含有12个氨基酸的α-2球蛋白。血管紧张素原主要由肝脏持续产生并释放进入血液循环。肾素切断血管紧张素原的亮氨酸(Leu)和缬氨酸(Val)残基之间的肽键,生成十个氨基酸的肽angiotensin I 。Angiotensin I主要由肺内的血管紧张素转换酶(ACE)除去两个C-末端残基,从而转化为angiotensin II(AII)。
Angiotensin是一种多肽激素,会导致血管收缩,随之血压升高。Angiotensin还可刺激醛固酮的释放,导致肾远端钠潴留,从而使血压升高。
Figure1 Formula of Angiotensin I/II (1-6)
参考文献:
1. Basso N, Terragno NA (December 2001). "History about the discovery of the renin-angiotensin system". Hypertension 38 (6): 1246–9.
2. Richard A. Preston. et. (1998). “Age-Race Subgroup Compared With Renin Profile as Predictors of Blood Pressure Response to Antihypertensive Therapy”. JAMA. 1998;280(13):1168-1172.
3. Williams GH, Dluhy RG (2008). "Chapter 336: Disorders of the Adrenal Cortex". In Loscalzo J, Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL. Harrison's principles of internal medicine. McGraw-Hill Medical.
Physical Appearance | A solid |
Storage | Store at -20°C |
M.Wt | 801.89 |
Cas No. | 47896-63-9 |
Formula | C36H55N11O10 |
Synonyms | H2N-Asp-Arg-Val-Tyr-Ile-His-OH |
Solubility | insoluble in EtOH; ≥62.4 mg/mL in H2O; ≥80.2 mg/mL in DMSO |
Chemical Name | 2-amino-4,6-dimethyl-3-oxo-1-N,9-N-bis[(3R,6S,7S,10S,16S)-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide |
SDF | Download SDF |
Canonical SMILES | CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)N)C |
运输条件 | 蓝冰运输或根据您的需求运输。 |
一般建议 | 不同厂家不同批次产品溶解度各有差异,仅做参考。若实验所需浓度过大至产品溶解极限,请添加助溶剂助溶或自行调整浓度。溶液形式一般不宜长期储存,请尽快用完。 |
质量控制和MSDS
- 批次: